Psychotropic actions of BW 234U in the treatment of inpatient schizophrenics: A dose‐range study

@article{Guy1983PsychotropicAO,
  title={Psychotropic actions of BW 234U in the treatment of inpatient schizophrenics: A dose‐range study},
  author={W. Guy and G. Manov and W. Wilson and T. A. Ban and O. K. Fjetland and P. J. Manberg and A. T. Dren},
  journal={Drug Development Research},
  year={1983},
  volume={3}
}
  • W. Guy, G. Manov, +4 authors A. T. Dren
  • Published 1983
  • Medicine
  • Drug Development Research
  • In a 28‐day, dose‐range study, 11 chronic schizophrenic inpatients newly admitted to the hospital with acute exacerbations were administered a new antipsychotic, BW 234U, in daily doses ranging from 100 to 400 mg/day on a fixed/flexible schedule to determine therapeutic dose range, safety, and psychotropic activity with special regard to possible antiaggressive action. The results of weekly assessments with standard psychiatric rating instruments indicate that BW 234U has dual psychotropic… CONTINUE READING
    15 Citations
    Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
    • 151
    • PDF

    References

    SHOWING 1-4 OF 4 REFERENCES
    Apomorphine-induced aggression in the rat.
    • 88
    ECDEU Assessment Manual for Psychopharmacology
    • 1976